This inventor holds 17 USPTO granted patents and 1 published patent application, plus 1 CIPO patent, primarily in Pharmaceutical Formulations. Top assignee: Adolor Corporation. Active years: 1997-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Exton, PA (US) (1997 - 2004)
- Philadelphia, PA (US) (1998 - 2007)
Company Filing History:
Years Active: 1997-2007
Areas of Expertise:
Title: Michael Anthony Marella: Innovator in Kappa Agonist Compounds
Introduction
Michael Anthony Marella is a prominent inventor based in Exton, Pennsylvania, known for his significant contributions to the field of pharmaceutical formulations. With a total of 17 patents to his name, Marella has made notable advancements in the development of kappa opioid agonist compounds.
Latest Patents
Marella's latest patents focus on kappa agonist compounds and their pharmaceutical formulations. These patents include compounds that exhibit kappa opioid agonist activity, along with methods for using them as analgesics and pruritic agents. The compounds are represented by specific formulae, which detail their structure and potential applications. His work provides methods for the prevention and treatment of pruritus, emphasizing the administration of effective amounts of kappa opioid receptor agonist compounds to patients.
Career Highlights
Throughout his career, Marella has been associated with Adolor Corporation, where he has played a crucial role in research and development. His innovative work has contributed to the advancement of pain management therapies and has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Marella has collaborated with notable colleagues, including Alan L. Maycock and Virendra Kumar, who have contributed to his research endeavors and the development of his patented technologies.
Conclusion
Michael Anthony Marella's contributions to the field of kappa agonist compounds and pharmaceutical formulations highlight his innovative spirit and dedication to improving patient care. His work continues to influence the pharmaceutical landscape, paving the way for new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile